For decades, embryo technologies were viewed as tools reserved for seedstock breeders, show-focused programs or those chasing the absolute top end of pedigree-driven genetics. But today, the economics ...

A study reported that the conventional method of searching follicular fluid didn’t find all the eggs. The new technology ...

Pregnant immigrants in Minnesota have been postponing their abortions, skipping aftercare, and delaying birth control visits ...

Students in Pamela McElmoyle’s seventh-grade science classes at L. B. Morris Elementary School in Jim Thorpe are getting a ...

Pfizer Inc. today announced positive topline progression-free (PFS) survival results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in ...

IVF with donor eggs offers a hopeful path to conception when natural or standard IVF attempts are not possible. The process ...

Planned Parenthood’s no-show rate has gone up almost 10 percent since the federal government’s Minnesota operation began.

Patients are also skipping time-sensitive reproductive services such as cervical cancer screenings due to fear of ICE.

Roughly 15% of couples worldwide experience infertility, and IVF success rates often remain below 33%. A major challenge is ...

Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...

Advances in fertility medicine have created situations the law never anticipated. Frozen embryos, eggs, and sperm can exist ...

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...